An Expert Opinion on the Management of Frailty in Heart Failure from the Australian Cardiovascular Alliance National Taskforce
Open Access
- 19 March 2025
- journal article
- review article
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 34 (7) , 693-703
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council
This publication has 89 references indexed in Scilit:
- Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐PreservedJournal of Cachexia, Sarcopenia and Muscle, 2023
- Frailty and heart failure: State‐of‐the‐art reviewJournal of Cachexia, Sarcopenia and Muscle, 2023
- Practical guidelines for exercise prescription in patients with chronic heart failureHeart Failure Reviews, 2023
- Participation of Older Adults in Clinical Trials for New Drug Applications and Biologics License Applications From 2010 Through 2019JAMA Network Open, 2022
- Exercise and Nutritional Interventions on Sarcopenia and Frailty in Heart Failure: A Narrative Review of Systematic Reviews and Meta-AnalysesESC Heart Failure, 2022
- Resistance training in heart failure patients: a systematic review and meta-analysisHeart Failure Reviews, 2021
- Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study ( US , UK and Sweden)European Journal of Heart Failure, 2021
- Aging and age‐related diseases: from mechanisms to therapeutic strategiesBiogerontology, 2021
- The Frailty Syndrome and Outcomes in the TOPCAT TrialEuropean Journal of Heart Failure, 2018
- A Drug Burden Index to Define the Functional Burden of Medications in Older PeopleArchives of internal medicine (1960), 2007